Search results
Nov 13, 2023 · Paxlovid is an oral antiviral medication used to treat COVID-19. Previous studies demonstrate the medication’s effectiveness in reducing hospitalization and death in cases of severe COVID-19. Since the integration of Paxlovid into COVID-19 treatment, some patients have reported virologic rebound.
Mar 25, 2024 · What is the rebound effect of Paxlovid? There have been reports of a “rebound” of COVID symptoms in some people within 2 to 8 days after completing the five-day course of Paxlovid; in those cases, some have tested positive again but have no symptoms; others have a recurrence of symptoms.
Feb 20, 2024 · Does Paxlovid cause rebound symptoms? A CDC review of COVID rebound studies found “no consistent association between treatment and rebound.” Paxlovid does not directly cause symptoms to return; in fact, only about 1 in 5 people who take Paxlovid experience rebound, and many of those are asymptomatic.
Dec 21, 2023 · Rebound of SARS-CoV-2 shedding or COVID-19 signs and symptoms has been described after treatment with nirmatrelvir/ritonavir (Paxlovid). The direct association of nirmatrelvir/ritonavir to COVID-19 rebound remains unclear because most reports are based on individual cases or nonrandomized studies.
May 24, 2022, 9:00 AM ET CDCHAN-0467. COVID-19 Rebound After Paxlovid Treatment. Summary. The Centers for Disease Control and Prevention (CDC) is issuing this Health Alert Network (HAN) Health Advisory to update healthcare providers, public health departments, and the public on the potential for recurrence of COVID-19 or “COVID-19 rebound.”
Dec 21, 2023 · Abstract. Early treatment with a first-line therapy (nirmatrelvir/ritonavir [Paxlovid] or remdesivir) or second-line therapy (molnupiravir) prevents hospitalization and death among patients with mild-to-moderate COVID-19 who are at risk for severe disease and is recommended by the National Institutes of Health COVID-19 Treatment Guidelines.
Dec 13, 2022 · Dec. 13, 2022, 12:57 p.m. ET. Reports of “Paxlovid rebound” popped up in the spring of 2022, as some people who had taken the antiviral medication experienced a recurrence of Covid symptoms,...
